• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Dova Pharmaceuticals

Quote
anonymous said:
Nightmare in the west with a toxic nsm, 2 managers fired last week and she said nothing on the call. Classic karen who doesn't concern herself with us "little people" who actually need their jobs so at least you have JM in the east, who has been a good rbd.
Click to expand...
the first thing this karen did was fire our excellent manager and put many cams on pips. we've all seen this toxic type before, you have to report their abusive behavior to higher managers and hr because they always brown nose those above them.
 












anonymous said:
the first thing this karen did was fire our excellent manager and put many cams on pips. we've all seen this toxic type before, you have to report their abusive behavior to higher managers and hr because they always brown nose those above them.
Click to expand...
People seem to be complaining about her to other managers. Not sure what will happen
 












anonymous said:
the first thing this karen did was fire our excellent manager and put many cams on pips. we've all seen this toxic type before, you have to report their abusive behavior to higher managers and hr because they always brown nose those above them.
Click to expand...
Wow you called this right! Did you see her with HK on the call? This sure didn't look or sound like the karen who rode with me and threatened to fire me!
 




anonymous said:
Don't count on hanging on since they are in desperation mode, could care less about how many careers they ruin, and they are targeting many more scapegoats to fire. It was the CEO's stupid, arrogant error that caused all this but the blame is being placed (as always!) on the field.
Click to expand...
we are hearing that with the CTI disaster and vonjo sales still far below target after over a year. (and with dual therapies with jak just a few months away) that they are ready to cut their losses in hem. has anyone heard anything specific?
 




anonymous said:
we are hearing that with the CTI disaster and vonjo sales still far below target after over a year. (and with dual therapies with jak just a few months away) that they are ready to cut their losses in hem. has anyone heard anything specific?
Click to expand...
This sounds accurate with the walls closing in on the Hematology division from all sides, including Doptelet going generic. Gout is the next big thing in the US and Hematology will either be sold off or reduced to a small fraction of its size, like with Synagis. Months not years.
 




This could be totally polishing a turd but hearing hematology is still important. Think of all the new resources and people they are throwing into the mix. Heard they are also looking for another acquisition
 




























Similar threads

Anyone have experience working for Madrigal Pharmaceuticals?
Replies
9
Views
4K
Biotech Startups
anonymous
Madrigal Pharmaceuticals
Replies
380
Views
80K
Biotech Startups
anonymous
BioCryst Pharmaceuticals
Replies
1
Views
2K
Biotech Startups
anonymous
Eagle Pharmaceuticals
Replies
14
Views
5K
Biotech Startups
anonymous
Kiniksa Pharmaceuticals
Replies
7
Views
5K
Biotech Startups
anonymous
Top Bottom
Back
Quote